Courage Miller Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$376K Hold
325
– – 0.1% 72
2026
Q2
$390K Hold
325
– – 0.1% 71
2026
Q1
$299K Hold
325
– – 0.08% 79
2025
Q4
$349K Hold
325
– – 0.11% 67
2025
Q3
$248K Hold
325
– – 0.07% 78
2025
Q2
$253K Hold
325
– – 0.08% 79
2025
Q1
$268K Sell
325
-2
-0.6% -$1.66K 0.09% 74
2024
Q4
$252K Hold
327
– – 0.09% 75
2024
Q3
$290K Hold
327
– – 0.1% 72
2024
Q2
$296K Hold
327
– – 0.11% 69
2024
Q1
$254K Buy
+327
New +$233K 0.09% 81

Other funds holding LLY

Courage Miller Partners's LLY Position: Q3 2026 in Review

Courage Miller Partners held its Eli Lilly (LLY) position steady in Q3 2026 at 325 shares worth $376K. The position accounts for 0.1% of the portfolio, ranked #72.

Courage Miller Partners first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $390K in Q2 2026. 1,273 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Courage Miller Partners held 325 shares of Eli Lilly worth $376K as of Q3 2026.
  • Courage Miller Partners left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.1% of Courage Miller Partners's portfolio in Q3 2026, its #72 holding.
  • Courage Miller Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
  • Courage Miller Partners's Eli Lilly position peaked at $390K in Q2 2026.
  • 1,273 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Courage Miller Partners's 13F filing for Q3 2026, filed 21 Oct 2026.